Supplemental Figure 2 from CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Supplemental Figure 2 from <i>CDKN2A/B</i> Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition2024
2. 2Supplemental Figure 3 from <i>CDKN2A/B</i> Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition2024
3. 3Supplemental Figure 3 from <i>CDKN2A/B</i> Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition2024
4. 4Supplemental Figure 1 from <i>CDKN2A/B</i> Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition2024
5. 5Supplemental Figure 1 from <i>CDKN2A/B</i> Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 Inhibition2024